These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 21596236
1. Mycophenolate mofetil decreases atherosclerotic lesion size by depression of aortic T-lymphocyte and interleukin-17-mediated macrophage accumulation. von Vietinghoff S, Koltsova EK, Mestas J, Diehl CJ, Witztum JL, Ley K. J Am Coll Cardiol; 2011 May 24; 57(21):2194-204. PubMed ID: 21596236 [Abstract] [Full Text] [Related]
2. Smooth Muscle Cell-Derived Interleukin-17C Plays an Atherogenic Role via the Recruitment of Proinflammatory Interleukin-17A+ T Cells to the Aorta. Butcher MJ, Waseem TC, Galkina EV. Arterioscler Thromb Vasc Biol; 2016 Aug 24; 36(8):1496-506. PubMed ID: 27365405 [Abstract] [Full Text] [Related]
3. Increased atherosclerotic lesion formation and vascular leukocyte accumulation in renal impairment are mediated by interleukin-17A. Ge S, Hertel B, Koltsova EK, Sörensen-Zender I, Kielstein JT, Ley K, Haller H, von Vietinghoff S. Circ Res; 2013 Sep 27; 113(8):965-74. PubMed ID: 23908345 [Abstract] [Full Text] [Related]
4. The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus. Richez C, Richards RJ, Duffau P, Weitzner Z, Andry CD, Rifkin IR, Aprahamian T. PLoS One; 2013 Sep 27; 8(4):e61042. PubMed ID: 23577189 [Abstract] [Full Text] [Related]
5. Mycophenolate mofetil but not atorvastatin attenuates atherosclerosis in lupus-prone LDLr(-/-) mice. van Leuven SI, Mendez-Fernandez YV, Wilhelm AJ, Wade NS, Gabriel CL, Kastelein JJ, Stroes ES, Tak PP, Major AS. Ann Rheum Dis; 2012 Mar 27; 71(3):408-14. PubMed ID: 21953346 [Abstract] [Full Text] [Related]
6. [The influence of mycophenolate mofetil upon the maturation and allostimulatory activity of cultured dendritic cell progenitors and the effects of tolerance induction in allograft recipients]. Han CH, Li HF, Wang YX, Zhang M, Wang Y, Yin M, Min ZL, Zheng KL. Zhonghua Yi Xue Za Zhi; 2005 May 25; 85(19):1327-32. PubMed ID: 16029632 [Abstract] [Full Text] [Related]
7. Mechanisms of action of mycophenolate mofetil in preventing acute and chronic allograft rejection. Allison AC, Eugui EM. Transplantation; 2005 Oct 15; 80(2 Suppl):S181-90. PubMed ID: 16251851 [Abstract] [Full Text] [Related]
8. Deficiency in lymphotoxin β receptor protects from atherosclerosis in apoE-deficient mice. Grandoch M, Feldmann K, Göthert JR, Dick LS, Homann S, Klatt C, Bayer JK, Waldheim JN, Rabausch B, Nagy N, Oberhuber A, Deenen R, Köhrer K, Lehr S, Homey B, Pfeffer K, Fischer JW. Circ Res; 2015 Apr 10; 116(8):e57-68. PubMed ID: 25740843 [Abstract] [Full Text] [Related]
9. IL-9 aggravates the development of atherosclerosis in ApoE-/- mice. Zhang W, Tang T, Nie D, Wen S, Jia C, Zhu Z, Xia N, Nie S, Zhou S, Jiao J, Dong W, Lv B, Xu T, Sun B, Lu Y, Li Y, Cheng L, Liao Y, Cheng X. Cardiovasc Res; 2015 Jun 01; 106(3):453-64. PubMed ID: 25784693 [Abstract] [Full Text] [Related]
10. Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Smith E, Prasad KM, Butcher M, Dobrian A, Kolls JK, Ley K, Galkina E. Circulation; 2010 Apr 20; 121(15):1746-55. PubMed ID: 20368519 [Abstract] [Full Text] [Related]
11. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells. Mehling A, Grabbe S, Voskort M, Schwarz T, Luger TA, Beissert S. J Immunol; 2000 Sep 01; 165(5):2374-81. PubMed ID: 10946260 [Abstract] [Full Text] [Related]
12. Down-regulation of multiple low dose streptozotocin-induced diabetes by mycophenolate mofetil. Maksimovic-Ivanic D, Trajkovic V, Miljkovic DJ, Mostarica Stojkovic M, Stosic-Grujicic S. Clin Exp Immunol; 2002 Aug 01; 129(2):214-23. PubMed ID: 12165076 [Abstract] [Full Text] [Related]
13. Mycophenolic acid suppresses granulopoiesis by inhibition of interleukin-17 production. von Vietinghoff S, Ouyang H, Ley K. Kidney Int; 2010 Jul 01; 78(1):79-88. PubMed ID: 20375992 [Abstract] [Full Text] [Related]
14. Overexpression of Cytotoxic T-Lymphocyte-Associated Antigen-4 Prevents Atherosclerosis in Mice. Matsumoto T, Sasaki N, Yamashita T, Emoto T, Kasahara K, Mizoguchi T, Hayashi T, Yodoi K, Kitano N, Saito T, Yamaguchi T, Hirata K. Arterioscler Thromb Vasc Biol; 2016 Jun 01; 36(6):1141-51. PubMed ID: 27055906 [Abstract] [Full Text] [Related]
15. Mechanisms of action of mycophenolate mofetil. Allison AC. Lupus; 2005 Jun 01; 14 Suppl 1():s2-8. PubMed ID: 15803924 [Abstract] [Full Text] [Related]
16. Protective role for Toll-like receptor-9 in the development of atherosclerosis in apolipoprotein E-deficient mice. Koulis C, Chen YC, Hausding C, Ahrens I, Kyaw TS, Tay C, Allen T, Jandeleit-Dahm K, Sweet MJ, Akira S, Bobik A, Peter K, Agrotis A. Arterioscler Thromb Vasc Biol; 2014 Mar 01; 34(3):516-25. PubMed ID: 24436372 [Abstract] [Full Text] [Related]
17. Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection. Klupp J, van Gelder T, Dambrin C, Regieli JJ, Boeke K, Billingham ME, Morris RE. J Heart Lung Transplant; 2004 Mar 01; 23(3):334-51. PubMed ID: 15019644 [Abstract] [Full Text] [Related]
18. Insulin-Like Growth Factor-1 Receptor Deficiency in Macrophages Accelerates Atherosclerosis and Induces an Unstable Plaque Phenotype in Apolipoprotein E-Deficient Mice. Higashi Y, Sukhanov S, Shai SY, Danchuk S, Tang R, Snarski P, Li Z, Lobelle-Rich P, Wang M, Wang D, Yu H, Korthuis R, Delafontaine P. Circulation; 2016 Jun 07; 133(23):2263-78. PubMed ID: 27154724 [Abstract] [Full Text] [Related]
19. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice. Yin M, Liu Q, Yu L, Yang Y, Lu M, Wang H, Luo D, Rong X, Tang F, Guo J. J Vasc Res; 2017 Jun 07; 54(3):123-130. PubMed ID: 28448973 [Abstract] [Full Text] [Related]
20. Mycophenolate mofetil and daclizumab targeting T lymphocytes in bleomycin-induced experimental scleroderma. Ozgen M, Koca SS, Dagli AF, Gundogdu B, Ustundag B, Isik A. Clin Exp Dermatol; 2012 Jan 07; 37(1):48-54. PubMed ID: 22182434 [Abstract] [Full Text] [Related] Page: [Next] [New Search]